Latest From Biotech Now

Patents Not an Issue in the Fight Against Ebola

shutterstock_26191726

As of October 23,2014 more than 4,900 people have died from the current Ebola outbreak, concentrated in the three West African countries of Sierra Leone, Guinea, and Liberia. Frustrated that the process of getting experimental vaccines to West Africa was not moving fast enough, some were quick to blame intellectual property rights. But in reality, as government officials were quick to point out, the WHO first needed to resolve important ethical and safety considerations before a vaccine that Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Need for Patent Reform May be Overblown

admin-ajax

Amid the cacophony of calls for patent reform legislation, mounting evidence demonstrates patent trolling may be on the wane. As we reported earlier this month, the number of new patent cases filed in federal court has dropped by an astonishing 40 percent as compared to this time last year. A new data analysis by Unified Patents data shows more signs that patent troll suits are in decline.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Shining A Light on Lung Cancer

Shine-A-Light115x76

Lung cancer is the leading cause of cancer death in the US, taking the lives of twice as many women as breast cancer and three times as many men as prostate cancer. While a history of smoking is the main risk factor for developing lung cancer, nearly 80% of those diagnosed today were never smokers or are former smokers who quit decades ago. November is Lung Cancer Awareness Month, a time of reflection for advocates Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Milwaukee Journal Sentinel Story on Use of Surrogate Measures

lab_tech

Earlier this week, John Fauber of the Milwaukee Journal Sentinel wrote an article on measures used to determine whether new medicines for serious and life-threatening diseases should reach patients. Fauber seem(s) to suggest that the use of surrogate measures – such as tumor shrinkage – do not provide evidence of drug efficacy. The story fails to present a balanced view of the complex benefit-risk assessments that the FDA must carefully consider when reviewing applications for Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

5 Arguments from the GMO Debate That Have Lost Their Gusto

GMO Debate

The Washington Post recently published a piece titled The GMO Debate: 5 Things to Stop Arguing, which looks at common arguments surrounding the use of genetically modified organism (GMOs) and how they have lost their vigor.  Specifically in her article, Tamar Haspel suggests 5 somethings taken from both sides of the debate that need to be retired. Haspel argues that moving beyond these 5 points could mean moving one step forward in achieving a happy medium between the two parties. 1. GMOs are Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,